BCL6 and B-cell non-Hodgkin lymphoma: Inhibitors of HSP90 have been shown to be effective in inducing apoptosis of B cell lymphomas that have a GC origin and overexpress B cell lymphoma-6 (BCL6) protein (Cerchietti et al., 2009).